Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:antibiotic
|
| gptkbp:activeIn |
gptkb:Neisseria_gonorrhoeae
Gram-negative bacteria multidrug-resistant bacteria |
| gptkbp:alternativeName |
afabicin
|
| gptkbp:clinicalTrialPhase |
Phase 2
|
| gptkbp:developedBy |
Debiopharm Group
|
| https://www.w3.org/2000/01/rdf-schema#label |
Debio 1347
|
| gptkbp:indication |
bacterial infections
|
| gptkbp:mechanismOfAction |
inhibits bacterial cell wall synthesis
|
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:target |
PBP2 (penicillin-binding protein 2)
|
| gptkbp:bfsParent |
gptkb:CD332
|
| gptkbp:bfsLayer |
7
|